The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS)
Clinical trial NCT04197453 · TERMINATED
Trial details
- NCT number
- NCT04197453
- Sponsor
- Amgen
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2019-12-06
- Primary completion
- 2020-12-21
- Enrollment
- 752
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.